tiprankstipranks
Advertisement
Advertisement
Geron: Early-Stage Rytelo Demand and Disciplined Investment Support Multi‑Year Growth and 2026 Reacceleration
PremiumRatingsGeron: Early-Stage Rytelo Demand and Disciplined Investment Support Multi‑Year Growth and 2026 Reacceleration
2M ago
Geron reports Q4 EPS (5c), consensus (4c)
Premium
The Fly
Geron reports Q4 EPS (5c), consensus (4c)
2M ago
Geron sees FY26 Rytelo revenue $220M-$240M
Premium
The Fly
Geron sees FY26 Rytelo revenue $220M-$240M
2M ago
Geron Issues 2026 Guidance Emphasizing RYTELO Growth
PremiumCompany AnnouncementsGeron Issues 2026 Guidance Emphasizing RYTELO Growth
3M ago
Geron sees FY26 RYTELO product revenue $220M-$240M
Premium
The Fly
Geron sees FY26 RYTELO product revenue $220M-$240M
3M ago
Geron Amends Term Loan Facility to Extend Draw Deadlines
Premium
Company Announcements
Geron Amends Term Loan Facility to Extend Draw Deadlines
3M ago
Cautious Hold Rating for Geron’s Imetelstat Amid Incremental Clinical Trial Updates
PremiumRatingsCautious Hold Rating for Geron’s Imetelstat Amid Incremental Clinical Trial Updates
4M ago
Geron announces new data presented at ASH 2025
Premium
The Fly
Geron announces new data presented at ASH 2025
4M ago
Unusually active option classes on open November 14th
Premium
The Fly
Unusually active option classes on open November 14th
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100